Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01614925 · ClinicalTrials.gov registry record
Safety and Efficacy of Periodontal Surgery in Supra-alveolar-type Defects With or Without Straumann® Emdogain
A clinical trial, sponsored by Institut Straumann.
- Terminated
- Registry status
- 35
- Enrollment target
NCT01614925 is a clinical trial that was terminated before completion, run by Institut Straumann. The registered enrollment target is 35 participants.
The verdict
NCT01614925 was terminated before completion, sponsored by Institut Straumann.
- TERMINATED
- Registry status
- 35 participants
- Enrollment target
Study Summary
The primary objective of this study is to demonstrate that in supra-alveolar-type defects (i.e., defects displaying a predominately horizontal pattern of bone loss), periodontal surgery with the additional use of Straumann® Emdogain will result in significantly higher Clinical Attachment Level (CAL) gain compared to periodontal surgery without Straumann® Emdogain.
Interventions
- PROCEDURE Periodontal surgery
- DEVICE Emdogain
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2012-11 |
| Est. Completion | 2014-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01614925
The ClinicalTrials.gov registry entry for NCT01614925 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Institut Straumann, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Periodontal surgery is the first listed.
NCT01614925 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01614925 about?
NCT01614925 is a clinical study titled "Safety and Efficacy of Periodontal Surgery in Supra-alveolar-type Defects With or Without Straumann® Emdogain". The primary objective of this study is to demonstrate that in supra-alveolar-type defects (i.e., defects displaying a predominately horizontal pattern of bone loss), periodontal surgery with the additional use of Straumann® Emdogain will result in significantly higher Clinical Attachment Level (CAL)...
What is the current status of trial NCT01614925?
This trial is currently terminated. The enrollment target is 35 participants. The study started on 2012-11. Estimated completion is 2014-10.
What interventions are being tested in trial NCT01614925?
The interventions under investigation include: Periodontal surgery (PROCEDURE), Emdogain (DEVICE).
Who is sponsoring clinical trial NCT01614925?
This trial is sponsored by Institut Straumann, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.